Ian F. Smith, EVP, CFO & COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,155 shares at $156.09 ($332K) on 2017-08-02, disclosed to the SEC on 2017-08-04.
Scheduled sale ($332k) by EVP, CFO & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.49 | 500 | $76K | 22.9% |
| 2 | $153.57 | 500 | $77K | 23.1% |
| 3 | $154.55 | 700 | $108K | 32.6% |
| 4 | $156.09 | 455 | $71K | 21.4% |
| Total | $154.17 avg | 2,155 | $332K | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |